The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deng, S.
Right arrow Articles by Markmann, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deng, S.
Right arrow Articles by Markmann, J. F.
The Journal of Immunology, 2006, 176: 2799-2807.
Copyright © 2006 by The American Association of Immunologists

Antibody-Induced Transplantation Tolerance That Is Dependent on Thymus-Derived Regulatory T Cells1

Shaoping Deng*, Daniel J. Moore{dagger}, Xiaolun Huang*, Mohammad Mohiuddin*, Major K. Lee, IV*, Ergun Velidedeoglu*, Moh-Moh Lian*, Meredith Chiaccio*, Samsher Sonawane*, Anton Orlin*, Jing Wang*, Haiying Chen*, Andrew Caton{ddagger}, Robert Zhong§ and James F. Markmann2,*

* Harrison Department of Surgical Research, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104; {dagger} Department of Pediatrics, Vanderbilt Children’s Hospital, Nashville, TN 37232; {ddagger} The Wistar Institute, Philadelphia, PA; and § Department of Surgery, University of Western Ontario, London, Ontario, Canada

Targeting of the CD45RB isoform by mAb (anti-CD45RB) effectively induces donor-specific tolerance to allografts. The immunological mechanisms underlying the tolerant state remain unclear although some studies have suggested the involvement of regulatory T cells (T-regs). Although their generative pathway remains undefined, tolerance promoting T-regs induced by systemic anti-CD45RB treatment have been assumed to originate in the peripheral immune system. We demonstrate herein that separable effects on the peripheral and central immune compartments mediate graft survival induced by anti-CD45RB administration. In the absence of the thymus, anti-CD45RB therapy is not tolerogenic though it retains peripheral immunosuppressive activity. The thymus is required for anti-CD45RB to produce indefinite graft survival and donor-specific tolerance, and this effect is accomplished through thymic production of donor-specific T-regs. These data reveal for the first time an Ab-based tolerance regimen that relies on the central tolerance pathway.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Deng, D. J. Moore, X. Huang, M.-M. Lian, M. Mohiuddin, E. Velededeoglu, M. K. Lee IV, S. Sonawane, J. Kim, J. Wang, et al.
Cutting Edge: Transplant Tolerance Induced by Anti-CD45RB Requires B Lymphocytes
J. Immunol., May 15, 2007; 178(10): 6028 - 6032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.